The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. LB Pharmaceuticals Inc shares valued at $30,000,000 were purchased by Deep Track Biotechnology Maste on Sep 12 ’25. At $15.00 per share, Deep Track Biotechnology Maste acquired 2,000,000 shares. The insider’s holdings grew to 2,686,138 shares worth approximately $44.4 million following the completion of this transaction.
Also, Deep Track Biotechnology Maste purchased 666,666 shares, netting a total of over 9,999,990 in proceeds. Following the buying of shares at $15.00 each, the insider now holds 666,666 shares.
Before that, Pontifax Management 4 G.P. (20 had added 1,000,000 shares to its account. In a trade valued at $15,000,000, the 10% Owner bought LB Pharmaceuticals Inc shares for $15.00 each. Upon closing the transaction, the insider’s holdings increased to 1,000,000 shares, worth approximately $23.34 million.
As published in their initiating research note from Stifel on October 06, 2025, LB Pharmaceuticals Inc [LBRX] has been a Buy and the price target has been revised to $27. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in early October. As of October 06, 2025, Leerink Partners has initiated its “an Outperform” rating for LBRX.
Analyzing LBRX Stock Performance
On last trading session, LB Pharmaceuticals Inc [NASDAQ: LBRX] rose 2.04% to $16.53. The stock’s lowest price that day was $15.955, but it reached a high of $17.0 in the same session. During the last five days, there has been a surge of approximately 4.13%.
Support And Resistance Levels for LB Pharmaceuticals Inc (LBRX)
According to the 24-hour chart, there is a support level at 15.99, which, if violated, would cause prices to drop to 15.45. In the upper region, resistance lies at 17.03. The next price resistance is at 17.54. RSI (Relative Strength Index) is 54.55 on the 14-day chart, showing neutral technical sentiment.
Is LB Pharmaceuticals Inc subject to short interest?
Stocks of LB Pharmaceuticals Inc saw a sharp steep in short interest on 2025-11-14 dropping by 26382.0 shares to 0.25 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.28 million shares. A decline of -10.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.54 of the overall float, the days-to-cover ratio (short ratio) decline to 2.54.
Which companies own the most shares of LB Pharmaceuticals Inc (LBRX)?
In terms of LB Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 30.5 in the next 12 months, up nearly 88.27% from the previous closing price of $16.2. Analysts anticipate LB Pharmaceuticals Inc stock to reach 34 by 2025, with the lowest price target being 27.
